Supreme Court to Address its First Biosimilars Dispute

The U.S. Supreme Court recently granted cross-petitions for certiorari in Sandoz Inc. v. Amgen and Amgen Inc. v. Sandoz Inc., marking the first time in which the Supreme Court will addresses issues arising under the Biologics Price Competition and Innovation Act of 2009.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news